FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] for Use in Individuals Ages 1 through 3 Years With a Confirmed Diagnosis of Peanut Allergy
FDA expands approval of Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to include individuals ages 1 through 3 years with peanut allergy to mitigate allergic reactions, including anaphylaxis, from accidental exposure. Palforzia, under a REMS, was initially approved in 2020 for ages 4 through 17 years. Users must still avoid peanuts in their diet.
Highlighted Terms
Related News
FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] for Use in Individuals Ages 1 through 3 Years With a Confirmed Diagnosis of Peanut Allergy
FDA expands approval of Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to include individuals ages 1 through 3 years with peanut allergy to mitigate allergic reactions, including anaphylaxis, from accidental exposure. Palforzia, under a REMS, was initially approved in 2020 for ages 4 through 17 years. Users must still avoid peanuts in their diet.